baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

IWG PLC/ JE00BYVQYS01 /

13/05/2024 17:29:47	Chg. +5.30	Volume	Bid17:30:00	Ask17:30:00	High	Low
200.40GBX	+2.72%	260,046 Turnover(GBP): 517,131.4570	-Bid Size: -	-Ask Size: -	201.00	195.50

GlobeNewswire 26/03 argenx Announces Approval of VYVGART (efgartigimod alfa) in Japan for Adults with Primary Immune Thr...

GlobeNewswire 11/12/2023 Keros Therapeutics Presents Clinical Data from its KER-050 Program at the 65th American Society of H...

GlobeNewswire 28/11/2023 argenx Reports Topline Results from ADVANCE-SC Study of VYVGART Hytrulo in Primary Immune Thrombocyt...

Newsfile Corp 05/10/2023 GoGlobal Announces Partnership with IWG to Offer Office Space and Hybrid Working Solutions to Client...

GlobeNewswire 24/02/2022 Teleflex Announces Fourth Quarter and Full-Year 2021 Financial Results

GlobeNewswire 13/12/2021 Corrected: Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050...

GlobeNewswire 13/12/2021 Keros Therapeutics Presents Clinical Trial and Preclinical Study Results from its KER-050 Program an...

GlobeNewswire 12/11/2021 Biosight Announces Initiation of Phase 2 Clinical Trial of Aspacytarabine for MDS and AML

GlobeNewswire 09/08/2021 HUTCHMED and Epizyme Announce Strategic Collaboration to Develop and Commercialize TAZVERIK® (tazeme...

GlobeNewswire 29/07/2021 Teleflex Reports Second Quarter 2021 Results and Full Year Outlook

GlobeNewswire 13/05/2021 Carbon180 Unveils Carbon Removal Policy Roadmap for 2021 and Beyond

GlobeNewswire 29/04/2021 Teleflex Reports First Quarter 2021 Results

GlobeNewswire 25/02/2021 Teleflex Reports Fourth Quarter and Full Year 2020 Results; Provides 2021 Guidance

GlobeNewswire 28/12/2020 Aprea Therapeutics Announces Results of Primary Endpoint from Phase 3 Trial of Eprenetapopt in TP53 ...

GlobeNewswire 06/12/2020 MacroGenics Presents Flotetuzumab Data in Patients with Refractory Acute Myeloid Leukemia at the 202...

GlobeNewswire 29/10/2020 Teleflex Reports Third Quarter 2020 Results

GlobeNewswire 30/07/2020 Teleflex Reports Second Quarter 2020 Results

GlobeNewswire 12/06/2020 Aprea Therapeutics Presents Results From French Phase Ib/II Clinical Trial of APR-246 (Eprenetapopt)...

GlobeNewswire 30/04/2020 Teleflex Reports First Quarter 2020 Results

GlobeNewswire 27/04/2020 MacroGenics Announces Presentation of Flotetuzumab Translational Data at the 2020 AACR Annual Meetin...

GlobeNewswire 20/02/2020 Teleflex Reports Fourth Quarter and Full Year 2019 Results; Provides 2020 Guidance

GlobeNewswire 12/12/2019 Recap and Update of Positive Data from Phase Ib/II Clinical Trials of APR-246 and Azacitidine (AZA) ...

GlobeNewswire 10/12/2019 Stemline Therapeutics Recaps ELZONRIS Clinical Data Presentations in Patients with Myelofibrosis (or...

GlobeNewswire 09/12/2019 MacroGenics Presents Flotetuzumab Data in Patients with Primary Induction Failure and Early Relapsed...

GlobeNewswire 09/12/2019 Aprea Therapeutics Presents Results From U.S. Phase Ib/II Clinical Trial of APR-246 and Azacitidine ...

IWG PLC/ JE00BYVQYS01 /

If you wish to receive reply to your feedback, please provide your email address.